FDA authorizes treatment, rapid test for COVID-19
March 30, 2020
Agency issues Emergency Use Authorization for hydroxychloroquine sulfate, along with a novel COVID-19 test.
Christine Blank
FDA expands hepatitis C treatment to children
March 24, 2020
Clinical trial results were similar to those of the drug in adults.
Drugmaker halts access to COVID drug as FDA approves novel test
March 24, 2020
First point-of-care test to detect coronavirus cleared.
FDA expedites coronavirus testing kits
March 17, 2020
The agency takes other steps to make COVID-19 tests more available.
FDA requires boxed warning on Singulair
March 16, 2020
New measures taken due to depression, suicidal thoughts, and other adverse events.
Top 3 Things to Know About Coronavirus Treatments
March 10, 2020
Discover the latest news on COVID-19 vaccine and drug development.
FDA, FTC warn suppliers of fraudulent COVID-19 products
March 10, 2020
Companies cited over false coronavirus claims include The Jim Bakker Show.
New multiple myeloma treatment works by targeting cells
March 3, 2020
Isatuximab-irfc (Sarclisa, Sanofi-Aventis) was approved in combination with pomalidomide and dexamethason to treat adult patients with multiple myeloma who have received at least two prior therapies.
FDA clears generic asthma inhaler, inhaled corticosteroid
March 3, 2020
Inhaler is the first generic approval of its kind.
FDA clears first-in-class high cholesterol drug
February 24, 2020
Treatment is first non-statin LDL-C lowering treatment approved in years.
